Print
Category: Uncategorised
Hits: 969
  Overall survival rates (IC95%)    
Diagnostic groups and subgroups     1y-OS   2y-OS        5y-OS  
I. Leukemias, myeloproliferative diseases, and myelodysplastic diseases 93.8 [93.2-94.3] 89.7 [89.0-90.4] 85.3 [84.4-86.1]
I.a Lymphoid leukemias 96.2 [95.7-96.7] 93.4 [92.7-94.0] 89.6 [88.7-90.4]
I.b Acute myeloid leukemias 83.9 [81.5-85.9] 75.0 [72.2-77.5] 68.1 [65.1-70.9]
II. Lymphomas and reticuloendothelial neoplasms 96.6 [95.8-97.2] 95.1 [94.2-95.9] 93.9 [92.9-94.7]
II.a Hodgkin lymphomas 99.5 [98.9-99.8] 98.6 [97.7-99.1] 97.3 [96.2-98.1]
II.b Non-Hodgkin lymphomas (except Burkitt lymphomas) 94.1 [92.3-95.5] 91.0 [88.9-92.8] 89.1 [86.8-91.1]
II.c Burkitt lymphomas 94.6 [92.6-96.0] 94.3 [92.2-95.8] 93.9 [91.8-95.5]
III. CNS and miscellaneous intracranial and intraspinal neoplasms 84.8 [83.9-85.7] 78.0 [76.9-79.0] 73.0 [71.9-74.1]
III.a Ependymomas and choroid plexus tumors 90.4 [87.8-92.5] 84.9 [81.7-87.5] 73.5 [69.6-77.0]
III.b Astrocytomas 92.2 [91.0-93.2] 87.9 [86.5-89.2] 86.0 [84.5-87.4]
III.c Intracranial and intraspinal embryonal tumors 74.1 [71.5-76.4] 64.2 [61.4-66.8] 54.1 [51.1-56.9]
III.d Other gliomas 61.7 [58.3-64.8] 43.9 [40.5-47.2] 37.7 [34.4-41.0]
III.e Other specified intracranial and intraspinal neoplasms 97.3 [96.2-98.1] 96.1 [94.8-97.1] 94.9 [93.4-96.0]
IV. Neuroblastomas and other peripheral nervous cell tumors 91.6 [90.4-92.8] 84.8 [83.2-86.3] 75.3 [73.3-77.1]
IV.a Neuroblastomas and ganglioneuroblastomas 91.7 [90.4-92.8] 84.8 [83.1-86.3] 75.1 [73.1-77.0]
V. Retinoblastomas 99.4 [98.5-99.8] 99.4 [98.5-99.8] 99.1 [98.1-99.6]
VI. Renal tumors 96.9 [95.9-97.7] 94.6 [93.3-95.7] 93.0 [91.5-94.2]
VI.a Nephroblastomas and other nonepithelial renal tumors 97.0 [96.0-97.8] 94.8 [93.5-95.9] 93.1 [91.6-94.3]
VII. Hepatic tumors 90.2 [85.9-93.3] 85.4 [80,5-89.2] 81.4 [75.9-85.7]
VII.a Hepatoblastomas 90.1 [85.3-93.4] 84.8 [79.2-89.0] 83.8 [78.1-88.1]
VIII. Malignant bone tumors 94.2 [92.7-95.4] 86.6 [84.5-88.4] 73.5 [70.8-76.1]
VIII.a Osteosarcomas 92.7 [90.2-94.6] 85.5 [82.3-88.2] 70.9 [66.7-74.6]
VIII.c Ewing tumors and related bone sarcomas 95.7 [93.6-97.1] 87.2 [84.0-89.7] 74.5 [70.4-78.2]
IX. Soft tissue and other extraosseous sarcomas 89.8 [88.2-91.1] 81.6 [79.6-83.4] 71.9 [69.5-74.1]
IX.a Rhabdomyosarcomas 92.1 [90.2-93.7] 83.2 [80.5-85.5] 72.3 [69.0-75.2]
IX.b Fibrosarcomas, peripheral nerve sheath tumors, and other fibrous neoplasms 91.4 [84.7-95.3] 85.3 [77.4-90.6] 77.0 [67.8-83.9]
IX.d Other specified soft tissue sarcomas 86.1 [82.8-88.8] 79.6 [75.8-82.9] 71.1 [66.8-74.9]
IX.e Unspecified soft tissue sarcomas 85.6 [77.8-90.8] 73.9 [64.8-81.0] 65.8 [56.1-73.9]
X. Germ-cell tumors, trophoblastic tumors, and neoplasms of gonads 96.2 [94.7-97.2] 94.9 [93.2-96.1] 93.6 [91.8-95.0]
X.a Intracranial and intraspinal germ cell tumors 96.1 [93.4-97.7] 94.9 [92.0-96.8] 93.9 [90.8-96.0]
X.b Malignant extracranial and extragonadal germ cell tumors 93.6 [89.9-96.0] 92.4 [88.5-95.0] 90.6 [86.3-93.6]
X.c Malignant gonadal germ cell tumors 98.7 [96.6-99.5] 98.0 [95.7-99.1] 97.4 [94.8-98.7]
XI. Other malignant epithelial neoplasms and malignant melanomas 96.3 [94.7-97.4] 94.2 [92.4-95.6] 92.6 [90.5-94.2]
XI.b Thyroid carcinomas 99.4 [97.8-99.9] 99.2 [97.4-99.7] 98.8 [96.9-99.6]
XI.d Malignant melanomas 92.9 [87.6-96.0] 91.6 [86.0-95.0] 87.5 [80.8-92.0]
XII. Other and unspecified malignant neoplasms 85.3 [72.8-92.4] 79.6 [66.1-88.2] 77.4 [63.6-86.5]
All cancers (excluding LCH) 91.9 [91.6-92.3] 87.2 [86.8-87.6] 82.3 [81.8-82.7]
Langherhans cell histiocytosis (LCH ) 93.3 [86.4-96.7] 92.3 [85.2-96.1] 92.3 [85.2-96.1]
All cancers (including LCH) 91.9 [91.6-92.3] 87.2 [86.8-87.6] 82.3 [81.8-82.8]

1y-OS, 2y-OS, 5y-OS : 1 year-, 2 year- and 5 year overall survival rate, respectively, with 95% confidence interval

Overall survival rates (OS) of childhood cancer in mainland France over 2000-2014, by diagnostic groups and subgroups